Yuzderm Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 38.32%
- Profit Growth 103.96%
- Ebitda 67.16%
- Net Worth 0.45%
- Total Assets 49.81%
About Yuzderm Pharmaceuticals
Yuzderm Pharmaceuticals Private Limited (YPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 2016 (Eight years and three months 0 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Chamriya and Ramji Hanath serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304MH2016PTC287820
- Company No.
287820
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Yuzderm Pharmaceuticals Private Limited offer?
Yuzderm Pharmaceuticals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Nutraceuticals & Dietary Supplements, Protein Powder, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Common Disease Medicines, Skin Lightening Drugs, Hair Care Cosmetics, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Yuzderm Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Chamriya  | Director | 21-Nov-2016 | Current |
| Ramji Hanath | Director | Current |
Financial Performance of Yuzderm Pharmaceuticals.
Yuzderm Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.32% increase. The company also saw a substantial improvement in profitability, with a 103.96% increase in profit. The company's net worth moved up by a moderate rise of 0.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yuzderm Pharmaceuticals?
In 2023, Yuzderm Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dlight Laboratories Private LimitedRajesh Chamriya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yuzderm Pharmaceuticals?
Yuzderm Pharmaceuticals has a workforce of 22 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yuzderm Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yuzderm Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
